ArticleJournal of managed care & specialty pharmacy2022

Cost-effectiveness and value of information analyses of Bruton's tyrosine kinase inhibitors in the treatment of relapsed or refractory mantle cell lymphoma in the United States.

Neda Alrawashdh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.